New York, March 21, 2023 (GLOBE NEWSWIRE) -- The Insight Partners, “Human Microbiome Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others) and Application (Therapeutics and Diagnostics) and Geography”, the global human microbiome market is estimated to reach $2,921.68 million by 2028 with 22.2% during 2021–2028, it was valued $718.95 million in 2021. The probiotics segment is expected to lead the market in 2021 with a share of 24.71%.
Download PDF Brochure at https://www.theinsightpartners.com/sample/TIPBT00002233
Global Human Microbiome Market Insights: Competition Landscape and Key Developments
Rebiotix Inc., Yakult Honsha Co., Ltd., Synthetic Biologics, Inc., DuPont, MaaT Pharma, Eligo Bioscience, Merck & Co., Inc, AOBiome LLC, Kaleido; and Seres Therapeutics are among the key companies operating in the human microbiome market. Leading players are focusing on the launch of new products, expansion and diversification of their market presence, and acquisition of other companies for tapping prevailing business opportunities.
In July 2021, Seres Therapeutics, Inc. and Nestlé Health Science entered into commercialization license agreement to jointly commercialize SER-109, Seres’ investigational oral microbiome therapeutic for recurrent Clostridioides difficile infection (CDI), in the US and Canada.
In June 2021, MaaT Pharma received Data Safety and Monitoring Board (DSMB) approval to proceed with the phase 1b trial cohort study for testing the capsule formulation of microbiome ecosystem therapy.
Patient Interactions with Lab Organizations Fuels Global Human Microbiome Market Growth:
As the human microbiome industry is growing in the coming years and the number of applications expands, new markets are emerging that use that human microbiome in different ways. Emerging markets in developing countries hold significant opportunities for the business expansion of major players. Most of the market players focusing on the emerging markets in Asia Pacific due to an increase in the prevalence of various diseases in the region. In June 2017, the Indian Human Microbiome Project was launched in the northeastern region for supporting the discovery of new drugs and pharmaceuticals. The project also provides new understanding on the mutual relationship between humans and associated microbial flora. Due to existing rates of currency exchange and several other factors, treatments in India are cheaper than other foreign countries.
Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPBT00002233
North America is expected to hold the largest share of the human microbiome market in 2021. Its dominance in the global market is ascribed to the high concentration of market players in the US and Canada, surge in the number of conferences and meetings, and rising prevalence of chronic diseases. In February 2018, the 3rd Annual North America Microbiome Congress was held in San Diego by Kisaco Research, with a major focus on the gut, lung, oral, skin, and vaginal microbiome niches; it provided latest insights on microbiome research, clinical trials, and collaborative partnerships.
Global Human Microbiome Market – Report Scope:
| Growth rate | CAGR of 22.2% from 2021-2028 |
| Market Size Value in | USD 718.95 Million in 2021 |
| Market Size Value by | USD 2,921.68 Million by 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
| No. of Pages | 188 |
| No. of Tables | 84 |
| No. of Charts & Figures | 78 |
| Historical data available | Yes |
| Segments covered | Product, Disease, Application and Geography |
| Regional scope | North America, Europe, Asia Pacific, Middle East & Africa, South & Central America |
| Country scope | US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Speak to Research Expert: https://www.theinsightpartners.com/speak-to-analyst/TIPBT00002233
Global Human Microbiome Market: Segmental Overview
Based on application, the human microbiome market is segmented into segmented into diagnostics and therapeutics. The therapeutics segment is expected to hold a larger share of the market in 2021 and is estimated to register the highest CAGR during the forecast period. Surge in digestive issues, increase in drug-related side-effects, and development of therapies for chronic diseases such as cancer are among the factors that are likely to propel the growth of the market for the therapeutics segment during the forecast period.
Based on product, the human microbiome market is segmented into foods, medical foods, probiotics, prebiotics, drugs, diagnostic devices, and supplements. The probiotics segment is expected to lead the market in 2021 with a share of 24.71%. Based on disease, the human microbiome market is segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders, and other diseases. The obesity segment is projected to hold the largest share of the market in 2021, whereas the diabetes segment is estimated to register the highest CAGR in the market during the forecast period. Based on application, the human microbiome market is segmented into diagnostics and therapeutics. The therapeutics segment is expected to hold a larger share of the market in 2021, and it is further estimated to register the highest CAGR during 2021–2028.
Buy Premium Copy of Human Microbiome Market Growth Report (2021-2028) at: https://www.theinsightpartners.com/buy/TIPBT00002233
Browse Adjoining Reports:
Human Microbiome Sequencing Technology Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Traditional Sequencing Technologies, Next-Generation Sequencing, Third Generation Sequencing); End User (Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Others) and Geography
Human Microbiome Sequencing Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type (Assay Kits, Instruments, Software); Technology (Next-Generation Sequencing, Traditional Sequencing Technologies, Other Sequencing Technologies); Application (Disease Diagnosis, Drug Discovery, Consumer Wellness, Omics Analysis, Other Applications); End Users (Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Other End Users)
Human Microbiome Based Drugs and Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Food, Probiotics, Prebiotics, Medical Food, Diagnostic Devices, Drugs, Other Probiotic Supplements); Application (Therapeutics, Diagnnostics); Disease (Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, Other Diseases); Research Spending, product Type (Instruments, Consumables); Research spending, Technology Type (Cell Culture Technology, High Throughput Technology, Omics Technology) and Geography
Human Microbiome Sequencing Instrument Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Reagents and Kits, Instruments, Liquid Handling Instruments, Cytometers, Imaging Devices, Microplate Reader, Others); Applications (Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Hospital and Clinic, Others) and Geography
Metagenomics Market to 2027 - Global Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Geography
Metagenomics Sequencing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Instruments, Reagents and Consumables, Software and Service); Technology (Shotgun Metagenomic Sequencing, RNA Sequencing, Whole-Genome Sequencing and De Novo Assembly, Metatranscriptomics); Application (Drug Discovery, Clinical Diagnostics, Others), and Geography
Microbiome Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Probiotics, Prebiotics, Small Molecules, Biological Drugs, Others.); Application (Autoimmune Diseases, Inflammatory Bowel Diseases, Cancer, Others.); End-Users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.) and Geography
Microbiome Sequencing Services Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Technology (Sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, Other technologies); Application (Diagnostics, Drug discovery, Others) and Geography
Microbiome Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Type 2 diabetes, Obesity, C. Difficile Infection, Primary Hyperoxyurea, Crohn's Disease, Inflammatory Bowel Diseases, Ulcerative Colitis); End User (Hospital, Clinics, Ambulatory Surgery Center, Others) and Geography
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/human-microbiome-market
